Variant report
Variant | esv3453687 |
---|---|
Chromosome Location | chr1:57949457-57950912 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs146085575 | chr1:57949461-57949462 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs557057149 | chr1:57949473-57949474 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs187888239 | chr1:57949488-57949489 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs61768066 | chr1:57949501-57949502 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs573699128 | chr1:57949511-57949512 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs542671514 | chr1:57949520-57949521 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs552914374 | chr1:57949552-57949553 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs573092279 | chr1:57949574-57949575 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs193102761 | chr1:57949622-57949623 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs537050113 | chr1:57949672-57949673 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs78941320 | chr1:57949674-57949675 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs182655218 | chr1:57949703-57949704 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs543527418 | chr1:57949742-57949743 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs148334598 | chr1:57949819-57949820 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs529326029 | chr1:57949835-57949836 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs549001361 | chr1:57949868-57949869 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs113024919 | chr1:57949896-57949897 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs559051559 | chr1:57949904-57949905 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs150763446 | chr1:57949908-57949909 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs552008470 | chr1:57949937-57949938 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs187658838 | chr1:57949964-57949965 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs537611514 | chr1:57949991-57949992 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs192765522 | chr1:57950031-57950032 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs116833637 | chr1:57950042-57950043 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs567400209 | chr1:57950068-57950069 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs111686138 | chr1:57950130-57950131 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs536341830 | chr1:57950137-57950138 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs552743454 | chr1:57950176-57950177 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs60813506 | chr1:57950281-57950282 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs538567104 | chr1:57950284-57950285 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs570613058 | chr1:57950381-57950382 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs115366391 | chr1:57950391-57950392 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs77921522 | chr1:57950405-57950406 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs553564664 | chr1:57950492-57950493 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs6679102 | chr1:57950556-57950557 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs560734397 | chr1:57950558-57950559 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs573836808 | chr1:57950570-57950571 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs139147406 | chr1:57950577-57950578 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs145273865 | chr1:57950596-57950597 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs183912635 | chr1:57950601-57950602 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs114844207 | chr1:57950658-57950659 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs115684833 | chr1:57950661-57950662 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs565603860 | chr1:57950664-57950665 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs188697972 | chr1:57950697-57950698 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs531213925 | chr1:57950718-57950719 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs144139164 | chr1:57950842-57950843 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs200943248 | chr1:57950850-57950851 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs147356513 | chr1:57950851-57950852 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs146528809 | chr1:57950852-57950853 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs60375797 | chr1:57950859-57950860 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Papillary thyroid carcinoma | 21436994 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Melanoma | 17363583 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Rett syndrome | 21593744 | CNVD |
Meckel-Gruber syndrome | 21572526 | CNVD |
Breast cancer | 16620391 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16608533 | CNVD |
Breast cancer | 21509527 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Developmental delay | 19490664 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 22522925 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Developmental delay | 21147756 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:57940200-57949600 | Weak transcription | NHDF-Ad | bronchial |
2 | chr1:57940800-57954800 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
3 | chr1:57943200-57955200 | Weak transcription | Stomach Mucosa | stomach |
4 | chr1:57945400-57949600 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
5 | chr1:57949400-57949600 | Enhancers | Hela-S3 | cervix |
6 | chr1:57949400-57949800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
7 | chr1:57949400-57950000 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
8 | chr1:57949600-57949800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
9 | chr1:57949600-57949800 | Enhancers | NH-A | brain |
10 | chr1:57949600-57949800 | Enhancers | NHEK | skin |
11 | chr1:57949600-57950000 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
12 | chr1:57949600-57950000 | Enhancers | NHLF | lung |
13 | chr1:57949600-57950800 | Weak transcription | Hela-S3 | cervix |
14 | chr1:57949600-57952200 | Enhancers | NHDF-Ad | bronchial |
15 | chr1:57949800-57951000 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
16 | chr1:57949800-57951200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
17 | chr1:57949800-57951200 | Weak transcription | NH-A | brain |
18 | chr1:57949800-57954600 | Weak transcription | NHEK | skin |
19 | chr1:57950000-57950400 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
20 | chr1:57950000-57951200 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
21 | chr1:57950000-57951200 | Weak transcription | NHLF | lung |
22 | chr1:57950400-57951800 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
23 | chr1:57950800-57952400 | Enhancers | Hela-S3 | cervix |